September 3, 2015

Biotechnology, Food & Drug Administration FDA News

Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
3
Sep
NLRB Says Beer Dealer’s Refusal-To-Drug-Test Firing Doesn’t Mix With “Weingarten Rights” Jackson Lewis P.C.
3
Sep
Another Claim Bites the Dust left by Teva v. Sandoz Schwegman, Lundberg & Woessner, P.A.
3
Sep
Long-Awaited Notice of Proposed Rulemaking for Federal Policy for the Protection of Human Subjects Released Drinker Biddle & Reath LLP
3
Sep
Update in Amgen v. Sandoz re: Biosimilar Applications Michael Best & Friedrich LLP
2
Sep
Minnesota Federal Court Finds “Field Preemption” of Minnesota Drug Testing Statute Jackson Lewis P.C.
1
Sep
Makers’ Mark Two: Bourbon Distiller Slips another “Handmade” False Advertising Suit Proskauer Rose LLP
1
Sep
Wait Continues for Release of First FSMA Final Rules Armstrong Teasdale
1
Sep
FDA’s New Four-Letter Guidance on Biosimilars Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
31
Aug
Getting Serious about Palcohol: Powdered Alcohol Drinker Biddle & Reath LLP
31
Aug
An Update on Biosimilar Activity in the U.S. Michael Best & Friedrich LLP
30
Aug
Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals Charged with Illegal Non-Compete for Generic ADHD Drug Sales Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
28
Aug
What’s in a Name? That Which We Call a Biological Product… Sheppard, Mullin, Richter & Hampton LLP
28
Aug
FDA’s Proposed Naming Convention for Biologics Foley & Lardner LLP
28
Aug
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
28
Aug
Amgen Inc., et al. v. Sandoz, Inc.: Shall Means Shall . . . Unless It Doesn’t McDermott Will & Emery
27
Aug
Food Standards of Identity Remain a Focus of FDA Regulatory Action Michael Best & Friedrich LLP
27
Aug
Sixth Circuit Assesses Class Action Criteria in Digestive Drug Litigation Squire Patton Boggs (US) LLP
27
Aug
Amgen And Apotex Do The Biosimilar Patent Dance Foley & Lardner LLP
26
Aug
Kyle Bass Loses Round 1 Of IPR Attack Against Pharma/Biotech Patents Foley & Lardner LLP
26
Aug
Trademarking: Capri Sun Says “Respect the Pouch” IMS ExpertServices

Pages

Advertisement

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, September 8, 2015
Wednesday, September 9, 2015
Thursday, September 17, 2015
Friday, September 18, 2015 to Saturday, September 19, 2015